Page last updated: 2024-10-24

carmustine and Chronic Lung Injury

carmustine has been researched along with Chronic Lung Injury in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YJ1
Kim, WS1
Choi, YH1
Cheon, JE1
Choi, JY1
Kang, HJ1
Park, JE1
Ryu, YJ1
Kim, IO1
White, CW1
Jackson, JH1
McMurtry, IF1
Repine, JE1

Other Studies

2 other studies available for carmustine and Chronic Lung Injury

ArticleYear
Radiologic evaluation of pulmonary injury following carmustine- and cyclophosphamide-based preparative regimen for autologous peripheral blood stem cell transplantation in children.
    Pediatric radiology, 2018, Volume: 48, Issue:13

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Carmustine; Child; Child, Preschool; Cyclophosphamide

2018
Hypoxia increases glutathione redox cycle and protects rat lungs against oxidants.
    Journal of applied physiology (Bethesda, Md. : 1985), 1988, Volume: 65, Issue:6

    Topics: 6-Aminonicotinamide; Animals; Carmustine; Glutathione; Hydrogen Peroxide; Hypoxia; In Vitro Techniqu

1988